Kathmandu�Hester Biosciences Nepal Private Limited, the joint venture company of Golchha Organization and Hester Biosciences Limited India, a leading health care company from India launched a new plant at Nala Ugrachandi in Kavre District near Kathmandu. Hester Biosciences Nepal Private Limited is a private sector unit which will be manufacturing animal vaccines. Amid a function held at Nala Ugrachandi on Wednesday Rt. Honorable Prime Minister, Mr. K.P. Sharma Oli inaugurated Hester Biosciences Nepal�s new plant.
Addressing the program, Rt. Hon. Prime Minister, Mr. K.P. Sharma Oli said, �Nepal is a country where most of people�s source of income is Livestock farming. The operation of Hester Biosciences in Nala will facilitate farmer in livestock production which contribute towards the economy growth, increase in household income and urbanization. More than 90% of the vaccines from Hester Biosciences are exported. With this plant in Nepal, there will be ample number of jobs creation and revenue generation as well.�
Honorable Minister for Finance Mr. Yubaraj Khatiwada expressed his joy in a venture that will help the economy in a sustainable way.
Mr. Rajiv Gandhi, CEO and Managing Director of Hester Biosciences Nepal said, �Emerging animal diseases have been a threat which needs to be addressed. We have advanced technology to manufacture vaccines and cure the animals. We believe our new plant with quality products and affordable price will help to reduce the problems faced by the farmers in livestock production.�
Hester has a state-of-the-art manufacturing facility for products ranging from poultry vaccines to large animal vaccines. The facility has been built as per GMP standards and norms, with an annual capacity to manufacture 1.24 billion doses of live and inactivated vaccines. Currently the company has 20 licensed vaccines and 27 vaccines which are under licensing.
Addressing the program, Rt. Hon. Prime Minister, Mr. K.P. Sharma Oli said, �Nepal is a country where most of people�s source of income is Livestock farming. The operation of Hester Biosciences in Nala will facilitate farmer in livestock production which contribute towards the economy growth, increase in household income and urbanization. More than 90% of the vaccines from Hester Biosciences are exported. With this plant in Nepal, there will be ample number of jobs creation and revenue generation as well.�
Honorable Minister for Finance Mr. Yubaraj Khatiwada expressed his joy in a venture that will help the economy in a sustainable way.
Mr. Rajiv Gandhi, CEO and Managing Director of Hester Biosciences Nepal said, �Emerging animal diseases have been a threat which needs to be addressed. We have advanced technology to manufacture vaccines and cure the animals. We believe our new plant with quality products and affordable price will help to reduce the problems faced by the farmers in livestock production.�
Hester has a state-of-the-art manufacturing facility for products ranging from poultry vaccines to large animal vaccines. The facility has been built as per GMP standards and norms, with an annual capacity to manufacture 1.24 billion doses of live and inactivated vaccines. Currently the company has 20 licensed vaccines and 27 vaccines which are under licensing.
